Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-formylphenoxyacetic Acid Isonicotinylhydrazone
2. Aconiazide
1. Aconiazide
2. Ncgc00160674-01
3. {2-[(e)-(isonicotinoylhydrazono)methyl]phenoxy}acetic Acid
4. Aconiazide [inn]
5. 8okq9ns8mo
6. 13410-86-1
7. Aconiazide [mart.]
8. Dsstox_cid_26292
9. Dsstox_rid_81518
10. Dsstox_gsid_46292
11. Schembl635283
12. Chembl1590674
13. Dtxsid8046292
14. Tox21_111977
15. Stk181710
16. Akos001031966
17. Cas-13410-86-1
18. Sr-01000872617
19. Sr-01000872617-2
20. Isonicotinic Acid (2-(carboxymethoxy)benzylidene)hydrazide
21. 2-(2-{[2-(4-pyridylcarbonyl)hydrazinylidene]methyl}phenoxy)acetic Acid
22. (2-{(e)-[2-(pyridin-4-ylcarbonyl)hydrazinylidene]methyl}phenoxy)acetic Acid
Molecular Weight | 299.28 g/mol |
---|---|
Molecular Formula | C15H13N3O4 |
XLogP3 | 1.3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 299.09060590 g/mol |
Monoisotopic Mass | 299.09060590 g/mol |
Topological Polar Surface Area | 101 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 408 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antitubercular Agents
Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. (See all compounds classified as Antitubercular Agents.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?